Literature DB >> 17892858

HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients.

Byung Lae Park1, Yoon Jun Kim, Hyun Sub Cheong, Soo Ok Lee, Chang Soo Han, Jung-Hwan Yoon, Ju Hyun Park, Hun Soo Chang, Choon-Sik Park, Hyo-Suk Lee, Hyoung Doo Shin.   

Abstract

Histone deacetylases (HDACs) are key enzymes responsible for the removal of acetyl groups from acetylated histone and non-histone proteins, and play important roles in various biological processes including transcription regulation and DNA repair. In this study, we identified 22 sequence variants by direct DNA sequencing in 24 individuals and five common variant were selected for genotyping in larger-scale subjects (n=1095). Statistical analysis revealed that HDAC10-589C>T was significantly associated with HCC occurrence among chronic HBV patients (OR=2.39, P(cor)=0.04) as well as HCC acceleration among chronic HBV patients (RH=1.97, Pcor=0.002). Functional assay also revealed that luciferase activity of "T" allele was significantly higher than that of "C" allele of HDAC10-589C>T (P=0.023). These results suggest that the "T" allele of HDAC10-589C>T affect on the increased transcription activity, and might accelerate HCC development through increased expression of HDAC10.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892858     DOI: 10.1016/j.bbrc.2007.09.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.

Authors:  Barbara Testoni; Christine Völlenkle; Francesca Guerrieri; Sabine Gerbal-Chaloin; Giovanni Blandino; Massimo Levrero
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

2.  HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.

Authors:  Xiangxiang Tao; Yifeng Yan; Linming Lu; Bing Chen
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

3.  Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.

Authors:  Annunziata Gloghini; Daniela Buglio; Noor M Khaskhely; Georgios Georgakis; Robert Z Orlowski; Sattva S Neelapu; Antonino Carbone; Anas Younes
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

Review 4.  Histone deacetylase 10, a potential epigenetic target for therapy.

Authors:  Fajuan Cheng; Bin Zheng; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 5.  HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities.

Authors:  Emily Koeneke; Olaf Witt; Ina Oehme
Journal:  Cells       Date:  2015-04-23       Impact factor: 6.600

6.  Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.

Authors:  Min-Sun Kwak; Dong Hyeon Lee; Yuri Cho; Eun-Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Jung-Hwan Yoon; Hyo-Suk Lee; Chung Yong Kim; Jae Youn Cheong; Sung Won Cho; Hyoung Doo Shin; Yoon Jun Kim
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 7.  Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.

Authors:  Fraczek Joanna; Leo A van Grunsven; Vinken Mathieu; Snykers Sarah; Deleu Sarah; Vanderkerken Karin; Vanhaecke Tamara; Rogiers Vera
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

8.  Functional polymorphism in aldehyde dehydrogenase-2 gene associated with risk of tuberculosis.

Authors:  Seung Kyu Park; Choon-Sik Park; Hyo-Suk Lee; Kyong Soo Park; Byung Lae Park; Hyun Sub Cheong; Hyoung Doo Shin
Journal:  BMC Med Genet       Date:  2014-04-02       Impact factor: 2.103

9.  SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy.

Authors:  Bei-Ge Jiang; Yuan Yang; Hui Liu; Fang-Ming Gu; Yun Yang; Lin-Hao Zhao; Sheng-Xian Yuan; Ruo-Yu Wang; Jin Zhang; Wei-Ping Zhou
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.